FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Neal Meropol

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Occupations

Medical Oncology

Activities & Behaviors

Co-author Network

Publications

TOP 3
Neal J Meropol; Jennifer L Millard; Suzanne M Miller; Eric A Ross; Kevin A Schulman; Allison Silver; Elyse Slater; Nicholas Solarino; Daniel P Sulmasy; Jonathan Trinastic; Andrew Balshem; Al B Benson; Joanne S Buzaglo; Donald J Cegala; Roger B Cohen; Michael Collins; Michael A Diefenbach; Brian L Egleston; Linda Fleisher; Kevin P Weinfurt
A Web-based communication aid for patients with cancer: the CONNECT Study.
Suzanne M Miller; N Solarino; J Trinastic; Jennifer Millard; Joanne S Buzaglo; K Devarajan; Brian L Egleston; Linda Fleisher; Shawna V Hudson; Sharon Manne; Neal J Meropol
The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.
C Aggarwal; N Y Gabrail; N Iannotti; Neal J Meropol; M C Miller; E Mitchell; M A Morse; Joel Picus; C J Punt; K D Sabbath; B H Saidman; S J Cohen
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Neal Meropol (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Neal J Meropol; Jennifer L Millard; Suzanne M Miller; Eric A Ross; Kevin A Schulman; Allison Silver; Elyse Slater; Nicholas Solarino; Daniel P Sulmasy; Jonathan Trinastic; Andrew Balshem; Al B Benson; Joanne S Buzaglo; Donald J Cegala; Roger B Cohen; Michael Collins; Michael A Diefenbach; Brian L Egleston; Linda Fleisher; Kevin P Weinfurt
A Web-based communication aid for patients with cancer: the CONNECT Study.
Cancer 2013;119(7):1437-45.
2013: Suzanne M Miller; N Solarino; J Trinastic; Jennifer Millard; Joanne S Buzaglo; K Devarajan; Brian L Egleston; Linda Fleisher; Shawna V Hudson; Sharon Manne; Neal J Meropol
The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.
Psycho-oncology 2013;22(3):481-9.
2013: C Aggarwal; N Y Gabrail; N Iannotti; Neal J Meropol; M C Miller; E Mitchell; M A Morse; Joel Picus; C J Punt; K D Sabbath; B H Saidman; S J Cohen
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(2):420-8.
2013: Kevin P Weinfurt; Scott Y Kim; Neal J Meropol
Talking with patients about dying.
The New England journal of medicine 2013;368(5):479.
2012: Kevin P Weinfurt; Damon M Seils; Daniel P Sulmasy; Alan B Astrow; Roger B Cohen; Herbert I Hurwitz; Li Lin; Neal J Meropol
Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4396-400.
2012: Susan Mazanec; Neal J Meropol; Barbara Daly; Mary Step
Facilitating enrollment in a Cancer Registry through modified consent procedures: a pilot study.
Journal of empirical research on human research ethics : JERHRE 2012;7(5):71-5.
2012: John Hornberger; Gary H Lyman; Rebecca Chien; Neal J Meropol
A multigene prognostic assay for selection of adjuvant chemotherapy in patients with T3, stage II colon cancer: impact on quality-adjusted life expectancy and costs.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(8):1014-21.
2012: Neal J Meropol
Comparative effectiveness research to inform medical decisions: the need for common language.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(34):4192-3.
2012: Tracy Klayton; Jonathan Cheng; Steven J Cohen; Lanea Keller; Tianyu Li; Neal J Meropol; Walter Scott; Meng Xu-Welliver; Jian Q Yu; Andre Konski
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.
Journal of gastrointestinal cancer 2012;43(4):612-8.
2012: Efrat Dotan; James Lee; Neal J Meropol; David Mintzer; Karen Ruth; Judi Sylvester; Holly Tuttle; Fang Zhu; Barbara Burtness; Crystal S Denlinger; Steven J Cohen
A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study.
Journal of gastrointestinal cancer 2012;43(4):562-9.
2012: Neal J Meropol; Nathan A Berger
Colon cancer recurrence: insights from the interface between epidemiology, laboratory science, and clinical medicine.
Journal of the National Cancer Institute 2012;104(22):1697-8.
2012: David O Bates; Al Bowen Benson; Paul J Catalano; Bruce J Giantonio; Neal J Meropol; Peter J O'Dwyer; Pramila Ramani; Kirsty E Symonds; Alex H R Varey; Steven J Harper
Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(22):6384-91.
2012: Joanna M Brell; Matthew M Cooney; Joseph A Bokar; Joseph Gibbons; Percy Ivy; Smitha S Krishnamurthi; Neal J Meropol; Linda Rath; Panayiotis Savvides; Afshin Dowlati
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2012;70(4):547-53.
2012: Andre Konski; Tianyu Li; Alan Maurer; Neal J Meropol; Walter Scott; Jeffrey Tokar; Jian Q Yu; Jonathan D Cheng; Michael Christensen; Steven J Cohen; Kevin Crawford; Oleh Haluszka; Gary M Freedman
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;104(1):72-7.
2012: Stuart J Wong; Kathryn Winter; Pramila Rani Anne; Beth A Erickson; Michael Haddock; Lisa Kachnic; Robert Jeffrey Lee; Neal J Meropol; Edith Mitchell; Jondavid Pollock; Asif Rashid; James C Watson; Christopher G Willett
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2012;82(4):1367-75.
2012: Neal J Meropol; Mark G Kris; Eric P Winer
The American Society of Clinical Oncology's Blueprint for Transforming Clinical and Translational Cancer Research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(7):690-1.
2012: Jonas A de Souza; Neal J Meropol; Lee N Newcomer; Monica Perkins; Blase Polite; Mark J Ratain; G Caleb Alexander
Unsupported off-label chemotherapy in metastatic colon cancer.
BMC health services research 2012;12():481.
2012: Jennifer R Eads; Neal J Meropol
A new era for the systemic therapy of neuroendocrine tumors.
The oncologist 2012;17(3):326-38.
2011: Neal J Meropol
Ongoing challenge of stage II colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(25):3346-8.
2011: Smitha S Krishnamurthi; Neal J Meropol
Colorectal carcinoma: overview of clinical research and management 2011.
Seminars in oncology 2011;38(4):481-2.
2011: Margaret A O'Grady; Elaine Sein; Elin R Sigurdson; Elyse Slater; Alan Weinstein; Paul F Engstrom; Patricia Keeley; Charles J Lusch; Neal J Meropol; Bonnie Miller; Steven J Cohen
Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative.
Clinical colorectal cancer 2011;10(2):113-6.
2011: Jill S Barnholtz-Sloan; Xiaowei Guan; Neal J Meropol; Charnita Zeigler-Johnson; Timothy R Rebbeck
Decision tree-based modeling of androgen pathway genes and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(6):1146-55.
2011: Navesh Sharma; Joshua S Silverman; Jian Q Yu; Tianyu Li; Neal J Meropol; Walter Scott; Jonathan Cheng; Steven J Cohen; Gary M Freedman; Oleh Haluszka; Andre Konski
Decreased Posttreatment SUV on PET Scan Is Associated With Improved Local Control in Medically Inoperable Esophageal Cancer.
Gastrointestinal cancer research : GCR 2011;4(3):84-9.
2011: Sarmad Sadeghi; Afsaneh Barzi; Michael W Kattan; Neal J Meropol
Screening for Lynch syndrome in the general population-letter.
Cancer prevention research (Philadelphia, Pa.) 2011;4(3):471; author reply 472.
2011: Michael J Hall; Sharon Manne; Gary Winkel; Daniel S Chung; David S Weinberg; Neal J Meropol
Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(2):249-54.
2011: Igor A Astsaturov; Neal J Meropol; R Katherine Alpaugh; Barbara Burtness; Jonathan D Cheng; Sue McLaughlin; André Rogatko; Zhiheng Xu; James C Watson; Louis M Weiner; Steven J Cohen
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma.
American journal of clinical oncology 2011;34(1):70-5.
2011: Charles D Blanke; Richard M Goldberg; Axel Grothey; Neal J Meropol; Margaret Mooney; Nancy Roach; Leonard B Saltz; John J Welch; William A Wood
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice.
The oncologist 2011;16(8):1061-8.
2011: Klara Berencsi; Pyapalli Rani; Tianqian Zhang; Laura Gross; Michael Mastrangelo; Neal J Meropol; Dorothee Herlyn; Rajasekharan Somasundaram
In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2.
Journal of translational medicine 2011;9():33.
2011: Neal J Meropol; Mary B Daly; Hetal S Vig; Frank J Manion; Sharon L Manne; Carla Mazar; Camara Murphy; Nicholas Solarino; Vadim Zubarev
Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility study.
Journal of telemedicine and telecare 2011;17(1):36-40.
2010: Lowell E Schnipper; Neal J Meropol; Dan W Brock
Value and cancer care: toward an equitable future.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(24):6004-8.
2010: Karyn B Stitzenberg; Neal J Meropol
Trends in centralization of cancer surgery.
Annals of surgical oncology 2010;17(11):2824-31.
2010: Rolf Swoboda; Rajasekharan Somasundaram; Laura Caputo; Klara Berencsi; Paul von Franzke; Douglas D Taylor; Francesco M Marincola; Neal J Meropol; Elin R Sigurdson; Eric Miller; Dorothee Herlyn
Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.
International journal of cancer. Journal international du cancer 2010;127(5):1124-30.
2010: Daniel P Sulmasy; Alan B Astrow; M Kai He; Damon M Seils; Neal J Meropol; Ellyn Micco; Kevin P Weinfurt
The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.
Cancer 2010;116(15):3702-11.
2010: Michael J Hall; Brian Egleston; Suzanne M Miller; Joanne S Buzaglo; Jennifer Millard; Caroline Ridgway; Nevena Damjanov; John D Sprandio; Neal J Meropol
Barriers to participation in cancer prevention clinical trials.
Acta oncologica (Stockholm, Sweden) 2010;49(6):757-66.
2010: Sharon L Manne; Neal J Meropol; David S Weinberg; Hetal Vig; Zohra Ali-Khan Catts; Cheri Manning; Eric Ross; Kristen Shannon; Daniel C Chung
Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(8):1366-72.
2010: Jennifer L Spratlin; Roger B Cohen; Matthew Eadens; Lia Gore; D Ross Camidge; Sami Diab; Stephen Leong; Cindy O'Bryant; Laura Q M Chow; Natalie J Serkova; Neal J Meropol; Nancy L Lewis; E Gabriela Chiorean; Floyd Fox; Hagop Youssoufian; Eric K Rowinsky; S Gail Eckhardt
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):780-7.
2010: Yu-Ning Wong; Olivia Hamilton; Brian L Egleston; Kevin Salador; Camara Murphy; Neal J Meropol
Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices.
The oncologist 2010;15(6):566-76.
2009: Hetal S Vig; Joanne Armstrong; Brian L Egleston; Carla Mazar; Michele Toscano; Angela R Bradbury; Mary B Daly; Neal J Meropol
Cancer genetic risk assessment and referral patterns in primary care.
Genetic testing and molecular biomarkers 2009;13(6):735-41.
2009: Crystal S Denlinger; Rebecca Blanchard; Lu Xu; Coen Bernaards; Samuel Litwin; Cynthia Spittle; Daniel J Berg; Susan McLaughlin; Maryann Redlinger; Andrew Dorr; Julie Hambleton; Scott Holden; Anne Kearns; Sara Kenkare-Mitra; Bert Lum; Neal J Meropol; Peter J O'Dwyer
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2009;65(1):97-105.
2009: Philip A Philip; Margaret Mooney; Deborah Jaffe; Gail Eckhardt; Malcolm Moore; Neal J Meropol; Leisha A Emens; Eileen O'Reilly; Murray Korc; Lee Ellis; Jacqueline Benedetti; Mace Rothenberg; Christopher Willett; Margaret Tempero; Andrew Lowy; James Abbruzzese; Diane M Simeone; Sunil Hingorani; Jordan Berlin; Joel E Tepper
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(33):5660-9.
2009: Efrat Dotan; Steven J Cohen; Katherine R Alpaugh; Neal J Meropol
Circulating tumor cells: evolving evidence and future challenges.
The oncologist 2009;14(11):1070-82.
2009: Karyn B Stitzenberg; Elin R Sigurdson; Brian L Egleston; Russell B Starkey; Neal J Meropol
Centralization of cancer surgery: implications for patient access to optimal care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4671-8.
2009: Sharon Manne; Elliot J Coups; Gary Winkel; Arnold J Markowitz; Neal J Meropol; Samuel Lesko; Paul B Jacobsen; Daniel Haller; Lina Jandorf; Susan K Peterson
Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer.
Health education research 2009;24(5):897-908.
2009: Richard M Goldberg; Neal J Meropol; Josep Tabernero
Accomplishments in 2008 in the treatment of advanced metastatic colorectal cancer.
Gastrointestinal cancer research : GCR 2009;3(5 Supplement 2):S23-7.
2009: Neal J Meropol; Deborah Schrag; Thomas J Smith; Therese M Mulvey; Robert M Langdon; Diane Blum; Peter A Ubel; Lowell E Schnipper
American Society of Clinical Oncology guidance statement: the cost of cancer care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3868-74.
2009: Michael Haley; Andre Konski; Tianyu Li; Jonathan D Cheng; Alan Maurer; Oleh Haluszka; Walter Scott; Neal J Meropol; Steven J Cohen; Gary Freedman
Influence of Diabetes on the Interpretation of PET Scans in Patients With Esophageal Cancer.
Gastrointestinal cancer research : GCR 2009;3(4):149-52.
2009: Steven J Cohen; Cornelis J A Punt; N Iannotti; B H Saidman; K D Sabbath; N Y Gabrail; Joel Picus; M A Morse; E Mitchell; M Craig Miller; G V Doyle; H Tissing; Leon W M M Terstappen; Neal J Meropol
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(7):1223-9.
2009: Yu-Ning Wong; Neal J Meropol; William Speier; Daniel Sargent; Richard M Goldberg; J Robert Beck
Cost implications of new treatments for advanced colorectal cancer.
Cancer 2009;115(10):2081-91.
2009: Andre Konski; Tianyu Li; Elin R Sigurdson; Steven J Cohen; William Small; Stewart Spies; Jian Q Yu; Andrew Wahl; Steven Stryker; Neal J Meropol
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
International journal of radiation oncology, biology, physics 2009;74(1):55-9.
2009: Neal J Meropol
The significance of circulating tumor cells as prognostic markers for colon cancer.
Clinical advances in hematology & oncology : H&O 2009;7(4):247-8.
2009: Sharon Manne; Elliot J Coups; Arnold J Markowitz; Neal J Meropol; Daniel Haller; Paul B Jacobsen; Lina Jandorf; Susan K Peterson; Samuel Lesko; Steven Pilipshen; Gary Winkel
A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings.
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 2009;37(2):207-17.
2009: Eileen Ke; Bhavinkumar B Patel; Tiffany Liu; Xin-Ming Li; Oleh Haluszka; John P Hoffman; Hormoz Ehya; Nancy A Young; James C Watson; David S Weinberg; Minhhuyen T Nguyen; Steven J Cohen; Neal J Meropol; Samuel Litwin; Jeffrey L Tokar; Anthony T Yeung
Proteomic analyses of pancreatic cyst fluids.
Pancreas 2009;38(2):e33-42.
2009: Martee Hensley; Karen L Hagerty; Tarun Kewalramani; Daniel M Green; Neal J Meropol; Todd H Wasserman; GARY COHEN; Bahman Emami; William J Gradishar; R Brian Mitchell; J Tate Thigpen; Andy Trotti; Daniel Von Hoff; Lynn M Schuchter
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):127-45.
2008: Neal J Meropol; Brian L Egleston; Joanne S Buzaglo; Al B Benson; Donald J Cegala; Michael A Diefenbach; Linda Fleisher; Suzanne M Miller; Daniel P Sulmasy; Kevin P Weinfurt
Cancer patient preferences for quality and length of life.
Cancer 2008;113(12):3459-66.
2008: Jaffer A Ajani; James S Barthel; Tanios Bekaii-Saab; David J Bentrem; Thomas A D'Amico; Charles S Fuchs; Hans Gerdes; James A Hayman; Lisa Hazard; David H Ilson; Lawrence Kleinberg; Mary Frances McAleer; Neal J Meropol; Mary F Mulcahy; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Aaron R Sasson; Walter J Scott; Stephen Shibata; Vivian E Strong; Stephen G Swisher; Mary Kay Washington; Christopher Willett; Douglas E Wood; Cameron D Wright; Gary Yang
Esophageal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):818-49.
2008: Neal J Meropol
Let's Focus on Value.
Journal of oncology practice / American Society of Clinical Oncology 2008;4(5):232.
2008: Kathryn E Flynn; Kevin P Weinfurt; Damon M Seils; Li Lin; Caroline B Burnett; Kevin Schulman; Neal J Meropol
Decisional conflict among patients who accept or decline participation in phase I oncology studies.
Journal of empirical research on human research ethics : JERHRE 2008;3(3):69-77.
2008: Steven J Cohen; R Katherine Alpaugh; Irma Palazzo; Neal J Meropol; André Rogatko; Zhiheng Xu; John P Hoffman; Louis M Weiner; Jonathan D Cheng
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Pancreas 2008;37(2):154-8.
2008: Matthew H Kulke; Heinz-Josef Lenz; Neal J Meropol; James Posey; David P Ryan; Joel Picus; Emily K Bergsland; Keith Stuart; Lesley Tye; Xin Huang; Jim Z Li; Charles M Baum; Charlie S Fuchs
Activity of sunitinib in patients with advanced neuroendocrine tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(20):3403-10.
2008: Steven J Cohen; Cornelis J A Punt; Nicholas Iannotti; Bruce H Saidman; Kert D Sabbath; Nashat Y Gabrail; Joel Picus; Michael Morse; Edith Mitchell; M Craig Miller; Gerald V Doyle; Henk Tissing; Leon W M M Terstappen; Neal J Meropol
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3213-21.
2008: Neal J Meropol; Donna Niedzwiecki; Brenda Shank; Thomas A Colacchio; John Ellerton; Frank Valone; Susan Budinger; Jeannette M Day; Judy Hopkins; Joel E Tepper; Richard M Goldberg; Robert J Mayer
Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3229-34.
2008: Kevin P Weinfurt; Damon M Seils; Janice P Tzeng; Kate L Compton; Daniel P Sulmasy; Alan B Astrow; Nicholas A Solarino; Kevin Schulman; Neal J Meropol
Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.
Medical decision making : an international journal of the Society for Medical Decision Making 2008;28(4):575-81.
2008: Linda Fleisher; Joanne S Buzaglo; Michael Collins; Jennifer Millard; Suzanne M Miller; Brian L Egleston; Nicholas Solarino; Jonathan Trinastic; Donald J Cegala; Al B Benson; Kevin Schulman; Kevin P Weinfurt; Daniel P Sulmasy; Michael A Diefenbach; Neal J Meropol
Using health communication best practices to develop a web-based provider-patient communication aid: the CONNECT study.
Patient education and counseling 2008;71(3):378-87.
2008: Robin Zon; Neal J Meropol; Robert B Catalano; Richard L Schilsky
American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2562-7.
2008: Daniel J Freeman; Todd Juan; Maureen Reiner; J Randolph Hecht; Neal J Meropol; Jordan Berlin; Edith Mitchell; Ildiko Sarosi; Robert Radinsky; Rafael G Amado
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone.
Clinical colorectal cancer 2008;7(3):184-90.
2008: Steven J Cohen; Paul F Engstrom; Nancy L Lewis; Corey J Langer; Susan McLaughlin; Mary Beard; Louis M Weiner; Neal J Meropol
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.
American journal of clinical oncology 2008;31(1):1-5.
2007: Kalyani Narra; Stefanie R Mullins; Hyung-Ok Lee; Brenda Strzemkowski-Brun; Kimberly Magalong; Victoria J Christiansen; Patrick A McKee; Brian Egleston; Steven J Cohen; Louis M Weiner; Neal J Meropol; Jonathan D Cheng
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer.
Cancer biology & therapy 2007;6(11):1691-9.
2007: Sharon Manne; Daniel C Chung; David S Weinberg; Hetal S Vig; Zohra Catts; Melissa Klein Cabral; Kristen Shannon; Neal J Meropol
Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(10):2110-7.
2007: Andre Konski; Jonathan D Cheng; Melvyn Goldberg; Tianyu Li; Alan Maurer; Jian Q Yu; Oleh Haluszka; Walter Scott; Neal J Meropol; Steven J Cohen; Gary Freedman; Louis M Weiner
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
International journal of radiation oncology, biology, physics 2007;69(2):358-63.
2007: Neal J Meropol; Joanne S Buzaglo; Jennifer Millard; Nevena Damjanov; Suzanne M Miller; Caroline Ridgway; Eric A Ross; John D Sprandio; Perry Watts
Barriers to clinical trial participation as perceived by oncologists and patients.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(8):655-64.
2007: J Randolph Hecht; Amita Patnaik; Jordan Berlin; Alan P Venook; Imtiaz Malik; Simon Tchekmedyian; Lynn Navale; Rafael G Amado; Neal J Meropol
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer.
Cancer 2007;110(5):980-8.
2007: Carmen Allegra; Charles D Blanke; Marc Buyse; Richard M Goldberg; Axel Grothey; Neal J Meropol; Leonard B Saltz; Alan P Venook; Greg Yothers; Daniel Sargent
End points in advanced colon cancer clinical trials: a review and proposal.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3572-5.
2007: Neal J Meropol
A renewed call for equipoise.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3392-4.
2007: Shirin Khambata-Ford; Christopher R Garrett; Neal J Meropol; Mark Basik; Christopher T Harbison; Shujian Wu; Tze Wai Wong; Xin Huang; Chris H Takimoto; Andrew K Godwin; Benjamin R Tan; Smitha S Krishnamurthi; Howard A Burris; Elizabeth A Poplin; Manuel Hidalgo; Jose Baselga; Edwin A Clark; David J Mauro
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3230-7.
2007: Bruce Giantonio; Paul J Catalano; Neal J Meropol; Peter J O'Dwyer; Edith P Mitchell; Steven R Alberts; Michael A Schwartz; Al B Benson
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1539-44.
2007: Anthony W Tolcher; Monica Mita; Neal J Meropol; Margaret von Mehren; Amita Patnaik; Kristin Padavic; Monique Hill; Theresa Mays; Therese McCoy; Norma Lynn Fox; Wendy Halpern; Alfred Corey; Roger B Cohen
Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1390-5.
2007: Gary M Freedman; Neal J Meropol; Elin R Sigurdson; John Hoffman; Elaine Callahan; Robert Price; Jonathan Cheng; Steve Cohen; Nancy Lewis; Deborah Watkins-Bruner; André Rogatko; Andre Konski
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2007;67(5):1389-93.
2007: Elliot J Coups; Sharon Manne; Neal J Meropol; David S Weinberg
Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(3):510-6.
2007: Klara Berencsi; Neal J Meropol; John P Hoffman; Elin R Sigurdson; Lydia Giles; Pyapalli Rani; Rajasekharan Somasundaram; Tianqian Zhang; Jiri Kalabis; Laura Caputo; Emma E Furth; Rolf Swoboda; Francesco M Marincola; Dorothee Herlyn
Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.
Cancer immunology, immunotherapy : CII 2007;56(3):359-70.
2007: Neal J Meropol; Kevin Schulman
Cost of cancer care: issues and implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(2):180-6.
2007: Joanne S Buzaglo; Jennifer Millard; Caroline G Ridgway; Eric A Ross; Susan P Antaramian; Suzanne M Miller; Neal J Meropol
An Internet method to assess cancer patient information needs and enhance doctor-patient communication: a pilot study.
Journal of cancer education : the official journal of the American Association for Cancer Education 2007;22(4):233-40.
2007: Richard M Goldberg; Mace L Rothenberg; Eric Van Cutsem; Al B Benson; Charles D Blanke; Robert B Diasio; Axel Grothey; Heinz-Josef Lenz; Neal J Meropol; Ramesh K Ramanathan; Carlos H Roberto Becerra; Rita Wickham; Delma Armstrong; Carol Viele
The continuum of care: a paradigm for the management of metastatic colorectal cancer.
The oncologist 2007;12(1):38-50.
2006: Benjamin Movsas; Hasmik Diratzouian; Alexandra Hanlon; Harry Cooper; Gary Freedman; Andre Konski; Elin R Sigurdson; John Hoffman; Neal J Meropol; Louis M Weiner; Lawrence R Coia; Rachelle Lanciano; Joanne Stein; Debra Kister; Burton L Eisenberg
Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
American journal of clinical oncology 2006;29(5):435-41.
2006: Manish Agrawal; Christine Grady; Diane Fairclough; Neal J Meropol; Kim Maynard; Ezekiel J Emanuel
Patients' decision-making process regarding participation in phase I oncology research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(27):4479-84.
2006: Neal J Meropol; Philip J Gold; Robert B Diasio; Michael Andria; Mandeep Dhami; Thomas Godfrey; Albert J Kovatich; Kirk A Lund; Edith Mitchell; Roland Schwarting
Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4069-77.
2006: Bruce Giantonio; D E Levy; Peter J O'Dwyer; Neal J Meropol; Paul J Catalano; Al B Benson
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(9):1399-403.
2006: Neal J Meropol
Turning point for colorectal cancer clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3322-4.
2006: Steven J Cohen; R Katherine Alpaugh; Steve Gross; S Mark O'Hara; Denis A Smirnov; Leon W M M Terstappen; W Jeffrey Allard; Maryann Bilbee; Jonathan D Cheng; John P Hoffman; Nancy L Lewis; Ann Pellegrino; André Rogatko; Elin R Sigurdson; Hao Wang; James C Watson; Louis M Weiner; Neal J Meropol
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Clinical colorectal cancer 2006;6(2):125-32.
2006: Jaffer A Ajani; Tanios Bekaii-Saab; Thomas A D'Amico; Charlie S Fuchs; Michael K Gibson; Melvyn Goldberg; James A Hayman; David H Ilson; Milind Javle; Scott Kelley; Robert C Kurtz; Gershon Yehuda Locker; Neal J Meropol; Bruce D Minsky; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Jack Roth; Aaron R Sasson; Stephen G Swisher; Douglas E Wood; Yun Yen
Gastric Cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(4):350-66.
2006: Jaffer A Ajani; Tanios Bekaii-Saab; Thomas A D'Amico; Charlie S Fuchs; Michael K Gibson; Melvyn Goldberg; James A Hayman; David H Ilson; Milind Javle; Scott Kelley; Robert C Kurtz; Gershon Yehuda Locker; Neal J Meropol; Bruce D Minsky; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Jack Roth; Aaron R Sasson; Stephen G Swisher; Douglas E Wood; Yun Yen
Esophageal Cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(4):328-47.
2006: Leonard R Henry; Melvyn Goldberg; Walter Scott; Andre Konski; Neal J Meropol; Gary Freedman; Louis M Weiner; Perry Watts; Mary Beard; Susan McLaughlin; Jonathan D Cheng
Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report.
Annals of surgical oncology 2006;13(2):214-20.
2006: Michael Collins; Eric Ross; Neal J Meropol; Amy B Lazev
Using metadata to generate web-based Electronic Data Capture Forms.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2006;():896.
2005: Andre Konski; John Hoffman; Elin R Sigurdson; Oleh Haluszka; Paul F Engstrom; Jonathan D Cheng; Steven J Cohen; James C Watson; Debra Eisenberg; Eileen McGarrity; Gary Freedman; Neal J Meropol
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience.
Seminars in oncology 2005;32(6 Suppl 9):S63-7.
2005: Steven J Cohen; Roger B Cohen; Neal J Meropol
Targeting signal transduction pathways in colorectal cancer--more than skin deep.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(23):5374-85.
2005: Mark L Sundermeyer; Neal J Meropol; André Rogatko; Hao Wang; Steven J Cohen
Changing patterns of bone and brain metastases in patients with colorectal cancer.
Clinical colorectal cancer 2005;5(2):108-13.
2005: Denis A Smirnov; Daniel R Zweitzig; Bradley W Foulk; M Craig Miller; Gerald V Doyle; Kenneth J Pienta; Neal J Meropol; Louis M Weiner; Steven J Cohen; Jose G Moreno; Mark C Connelly; Leon W M M Terstappen; S Mark O'Hara
Global gene expression profiling of circulating tumor cells.
Cancer research 2005;65(12):4993-7.
2005: Neal J Meropol
Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1791-3.
2005: Neal J Meropol
Colorectal cancer: looking forward.
Seminars in oncology 2005;32(1):1-2.
2005: Leslie E Carlini; Neal J Meropol; John Bever; Michael L Andria; Todd Hill; Philip Gold; André Rogatko; Hao Wang; Rebecca L Blanchard
UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1226-36.
2005: Linda Fleisher; Jennifer Millard; Stephanie Raivitch; Susan Antaramian; Michael Collins; Neal J Meropol
Usability testing to improve functionality and content for a web-based provider-patient communication tool.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2005;():956.
2005: Mary F Mulcahy; Patrick J Loehrer; Neal J Meropol; Alfred W Rademaker; Al B Benson Iii
A phase I study of docetaxel, Cisplatin, 5-Fluorouracil and leucovorin.
Oncology 2005;68(4-6):479-84.
2005: Kevin P Weinfurt; Venita DePuy; Liana D Castel; Daniel P Sulmasy; Kevin Schulman; Neal J Meropol
Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials.
Cancer 2005;103(1):140-7.
2004: Darrell J Gaskin; Kevin P Weinfurt; Liana D Castel; Venita DePuy; Yun Li; Andrew Balshem; Al Benson; Caroline B Burnett; Sandra Corbett; John Marshall; Elyse Slater; Daniel P Sulmasy; David A Van Echo; Neal J Meropol; Kevin Schulman
An exploration of relative health stock in advanced cancer patients.
Medical decision making : an international journal of the Society for Medical Decision Making 2004;24(6):614-24.
2004: Ahmad L Subhi; Baiqing Tang; binaifer Balsara; Deborah A Altomare; Joseph R Testa; Harry S Cooper; John P Hoffman; Neal J Meropol; warren kruger
Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7290-6.
2004: Steven J Cohen; James Gallo; Nancy L Lewis; R Katherine Alpaugh; Louis Gentner; André Rogatko; Gwen Yeslow; Jessie Schol; Tom Verhaeghe; Peter Zannikos; Peter A Palmer; Louis M Weiner; Neal J Meropol
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.
Cancer chemotherapy and pharmacology 2004;53(6):513-8.
2004: Nevena Damjanov; Neal J Meropol
Epidermal growth factor receptor inhibitors for the treatment of colorectal cancer: a promise fulfilled?
Oncology (Williston Park, N.Y.) 2004;18(4):479-88; discussion 488, 493, 497 passim.
2004: Leonard B Saltz; Neal J Meropol; Patrick J Loehrer; Michael Neil Needle; Justin Kopit; Robert J Mayer
Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1201-8.
2004: Inmaculada Ibanez de Caceres; Natalya Frolova; Robert J Varkonyi; Essel Dulaimi; Neal J Meropol; Dominique Broccoli; Paul Cairns
Telomerase is frequently activated in tumors with microsatellite instability.
Cancer biology & therapy 2004;3(3):289-92.
2004: Anthony F Shields; Mark M Zalupski; John L Marshall; Neal J Meropol
Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trial.
Cancer 2004;100(3):531-7.
2003: Salvatore Cortellino; David Paul Turner; Valeria Masciullo; Filippo Schepis; Domenico Albino; Rene Daniel; Anna Marie Skalka; Neal J Meropol; Christophe Alberti; Lionel Larue; Alfonso Bellacosa
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(25):15071-6.
2003: Nancy L Lewis; Neal J Meropol
Development of new agents for the treatment of advanced colorectal cancer.
Clinical colorectal cancer 2003;3(3):154-64.
2003: Lynn Schuchter; Neal J Meropol; Eric P Winer; Martee Hensley; Mark R Somerfield
Amifostine and chemoradiation therapy: ASCO responds.
The lancet oncology 2003;4(10):593.
2003: Kevin P Weinfurt; Liana D Castel; Yun Li; Daniel P Sulmasy; Andrew Balshem; Al B Benson; Caroline B Burnett; Darrell J Gaskin; John L Marshall; Elyse Slater; Kevin Schulman; Neal J Meropol
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
Cancer 2003;98(1):166-75.
2003: Neal J Meropol; Kevin P Weinfurt; Caroline B Burnett; Andrew Balshem; Al B Benson; Liana D Castel; Sandra Corbett; Michael A Diefenbach; Darrell J Gaskin; Yun Li; Sharon Manne; John Marshall; Julia H Rowland; Elyse Slater; Daniel P Sulmasy; David A Van Echo; Shakira Washington; Kevin Schulman
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2589-96.
2003: Neal J Meropol; Robert A Somer; John Gutheil; Robert J Pelley; Manuel R Modiano; Eric K Rowinsky; Mace L Rothenberg; Spencer Redding; Cuneyt M Serdar; Bin Yao; Robert Heard; Lee S Rosen
Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(8):1452-8.
2003: Steven J Cohen; Linus Ho; Sulabha Ranganathan; James L Abbruzzese; R Katherine Alpaugh; Mary Beard; Nancy L Lewis; Susan McLaughlin; André Rogatko; Juan Jose Perez-Ruixo; Amanda M Thistle; Tom Verhaeghe; Hao Wang; Louis M Weiner; John J Wright; Gary R Hudes; Neal J Meropol
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1301-6.
2003: Jeanne S Mandelblatt; Stephen B Edge; Neal J Meropol; Ruby T Senie; Theodore Tsangaris; Luther Grey; Burt M Peterson; Yi-Ting Hwang; Jon F Kerner; Jane C Weeks
Predictors of long-term outcomes in older breast cancer survivors: perceptions versus patterns of care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):855-63.
2003: Jaffer Ajani; Thomas A D'Amico; James A Hayman; Neal J Meropol; Bruce Minsky
Gastric cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1(1):28-39.
2003: Jaffer Ajani; Thomas A D'Amico; James A Hayman; Neal J Meropol; Bruce Minsky
Esophageal cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1(1):14-27.
2003: Aaron R Sasson; R Wesley Wetherington; John P Hoffman; Eric A Ross; Harry Cooper; Neal J Meropol; Gary Freedman; James F Pingpank; Burton L Eisenberg
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome.
International journal of gastrointestinal cancer 2003;34(2-3):121-8.
2003: Kevin P Weinfurt; Daniel P Sulmasy; Kevin Schulman; Neal J Meropol
Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception.
Theoretical medicine and bioethics 2003;24(4):329-44.
2003: Fairooz Kabbinavar; Herbert I Hurwitz; Louis Fehrenbacher; Neal J Meropol; William F Novotny; Grazyna Lieberman; Susan Griffing; Emily Bergsland
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(1):60-5.
2003: Sharon Manne; Arnold J Markowitz; Sidney J Winawer; Jose G Guillem; Neal J Meropol; Daniel Haller; Lina Jandorf; William Rakowski; James Babb; Terry Duncan
Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a mediational model.
Preventive medicine 2003;36(1):71-84.
2002: Jeanne S Mandelblatt; Stephen B Edge; Neal J Meropol; Ruby T Senie; Theodore Tsangaris; Luther Grey; Burt Peterson; Yi-Ting Hwang; Jane C Weeks
Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma.
Cancer 2002;95(12):2445-54.
2002: Gini F Fleming; Neal J Meropol; Gary Rosner; Donna Hollis; William E Carson; Michael Caligiuri; Joanne Mortimer; Katherine Tkaczuk; Robin Parihar; Richard L Schilsky; Mark J Ratain
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3718-27.
2002: Nancy L Lewis; Richard Scher; James M Gallo; Paul F Engstrom; Christine E Szarka; Samuel Litwin; Andrea L Adams; Deborah Kilpatrick; Diane Brady; Louis M Weiner; Neal J Meropol
Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed.
Cancer chemotherapy and pharmacology 2002;50(4):257-65.
2002: Steven J Cohen; Cynthia G Leichman; Gwen Yeslow; Mary Beard; April Proefrock; Brian Roedig; Bharat Damle; Stephen P Letrent; Arthur P DeCillis; Neal J Meropol
Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2116-22.
2002: Lynn Schuchter; Martee Hensley; Neal J Meropol; Eric P Winer
2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2895-903.
2002: Stephen B Edge; Karen Gold; Christine D Berg; Neal J Meropol; Theodore Tsangaris; Luther Gray; Bert M Petersen; Yi-Ting Hwang; Jeanne S Mandelblatt
Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma.
Cancer 2002;94(10):2534-41.
2002: Andrew L Pecora; Naiyer A Rizvi; GARY COHEN; Neal J Meropol; Daniel Sterman; John L Marshall; Stuart Goldberg; Peter Gross; James D O'Neil; William S Groene; M Scot Roberts; Harvey Rabin; Michael K Bamat; Robert M Lorence
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2251-66.
2002: J Pablo Arnoletti; John P Hoffman; Eric A Ross; Steven A Kagan; Neal J Meropol; Gary Freedman; Burton L Eisenberg
Preoperative chemoradiation in the management of adenocarcinoma of the body of the pancreas.
The American surgeon 2002;68(4):330-5; discussion 335-6.
2002: Wenchi Liang; Caroline B Burnett; Julia H Rowland; Neal J Meropol; Lynne Eggert; Yi-Ting Hwang; Rebecca A Silliman; Jane C Weeks; Jeanne S Mandelblatt
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):1008-16.
2002: Steven J Cohen; Neal J Meropol
Drug development in pancreatic cancer: finally, biology begets therapy.
International journal of gastrointestinal cancer 2002;32(2-3):91-106.
2002: Sharon Manne; Arnold J Markowitz; Sidney J Winawer; Neal J Meropol; Daniel Haller; William Rakowski; James Babb; Lina Jandorf
Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2002;21(1):3-15.
2001: Jeanne S Mandelblatt; Arlene S Bierman; Karen Gold; Y Zhang; J H Ng; N Maserejian; N Maserejan; Yi-Ting Hwang; Neal J Meropol; Jack Hadley; Rebecca A Silliman
Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods.
Health services research 2001;36(6 Pt 1):1085-107.
2001: William E Carson; Robin Parihar; Matthew Lindemann; N Personeni; Julie Dierksheide; Neal J Meropol; J Baselga; Michael A Caligiuri
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells.
European journal of immunology 2001;31(10):3016-25.
2001: Caroline B Burnett; B Koczwara; L Pixley; L E Blumenson; Yi-Ting Hwang; Neal J Meropol
Nurses' attitudes toward clinical trials at a comprehensive cancer center.
Oncology nursing forum 2001;28(7):1187-92.
2001: Margaret von Mehren; Philip M Arlen; James L Gulley; André Rogatko; Harry S Cooper; Neal J Meropol; R Katherine Alpaugh; M Davey; Susan McLaughlin; Mary Beard; Kwong-Yok Tsang; J Schlom; Louis M Weiner
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1181-91.
2001: Neal J Meropol; Donna Niedzwiecki; D Hollis; R L Schilsky; Robert J Mayer
Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma.
Cancer 2001;91(7):1256-63.
2001: James F Pingpank; John P Hoffman; Eric A Ross; Harry S Cooper; Neal J Meropol; Gary Freedman; Wayne H Pinover; T E LeVoyer; Aaron R Sasson; Burton L Eisenberg
Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2001;5(2):121-30.
2001: Aaron R Sasson; John P Hoffman; Eric Ross; Neal J Meropol; Christine E Szarka; Gary Freedman; Wayne H Pinover; James F Pingpank; Burton L Eisenberg
Trimodality therapy for advanced gallbladder cancer.
The American surgeon 2001;67(3):277-83; discussion 284.
2001: Jeanne S Mandelblatt; Christine D Berg; Neal J Meropol; Stephen B Edge; Karen Gold; Yi-Ting Hwang; Jack Hadley
Measuring and predicting surgeons' practice styles for breast cancer treatment in older women.
Medical care 2001;39(3):228-42.
2000: Steven J Cohen; Wayne H Pinover; James C Watson; Neal J Meropol
Pancreatic cancer.
Current treatment options in oncology 2000;1(5):375-86.
2000: Jeanne S Mandelblatt; Jack Hadley; Jon F Kerner; Kevin Schulman; Karen Gold; J Dunmore-Griffith; Stephen B Edge; Edward Guadagnoli; J J Lynch; Neal J Meropol; Jane C Weeks; R Winn
Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences.
Cancer 2000;89(3):561-73.
2000: Nevena Damjanov; Neal J Meropol
Oral therapy for colorectal cancer: how to choose.
Oncology (Williston Park, N.Y.) 2000;14(6):799-807; discussion 807-8, 813-4,.
2000: Margaret von Mehren; Philip M Arlen; Kwong-Yok Tsang; André Rogatko; Neal J Meropol; Harry S Cooper; M Davey; Susan McLaughlin; J Schlom; Louis M Weiner
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2219-28.
2000: Lakshmi Pendyala; Patrick J Creaven; Gary Schwartz; Neal J Meropol; W Bolanowska-Higdon; Joseph Zdanowicz; Michael Murphy; Raymond Perez
Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1314-21.
2000: Dah H Ho; W Covington; N Brown; S N Lin; Richard Pazdur; Y Y Huo; Patrick J Creaven; Youcef M Rustum; Neal J Meropol; Yvonne Lassere; Jun Kuritani; T Hayakawa
Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer.
Cancer chemotherapy and pharmacology 2000;46(5):351-6.
2000: Nancy L Lewis; Neal J Meropol
Oral fluoropyrimidines in cancer treatment.
Cancer investigation 2000;18(8):747-60.
2000: J D Cheng; J Hitt; B Koczwara; Kevin Schulman; Caroline B Burnett; Darrell J Gaskin; Julia H Rowland; Neal J Meropol
Impact of quality of life on patient expectations regarding phase I clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):421-8.
1999: Jonathan D Cheng; B A Werness; James S Babb; Neal J Meropol
Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1057-62.
1999: Neal J Meropol; Youcef M Rustum; Patrick J Creaven; L E Blumenson; C Frank
Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
Cancer investigation 1999;17(1):1-9.
1999: Neal J Meropol; Daryl Sonnichsen; M J Birkhofer; I Ferreira; Diane C Noel
Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Cancer chemotherapy and pharmacology 1999;43(3):221-6.
1998: G N Schwartz; Lakshmi Pendyala; H Kindler; Neal J Meropol; R Perez; D Raghavan; Patrick J Creaven
The clinical development of paclitaxel and the paclitaxel/carboplatin combination.
European journal of cancer (Oxford, England : 1990) 1998;34(10):1543-8.
1998: Neal J Meropol
Oral fluoropyrimidines in the treatment of colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(10):1509-13.
1998: Neal J Meropol; G M Barresi; Todd A Fehniger; J Hitt; M Franklin; Michael A Caligiuri
Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing.
Cancer immunology, immunotherapy : CII 1998;46(6):318-26.
1998: Daniel R Budman; Neal J Meropol; Bruno Reigner; Patrick J Creaven; Stuart M Lichtman; EJ Berghorn; J Behr; RJ Gordon; B Osterwalder; T Griffin
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1795-802.
1998: Neal J Meropol; L E Blumenson; Patrick J Creaven
Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorin.
American journal of clinical oncology 1998;21(2):135-8.
1998: Neal J Meropol; D E Wood; J Nemunaitis; N J Petrelli; B J Lipman; JM Agosti; JB Whitmore
Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1167-73.
1998: Darrell J Gaskin; J Kong; Neal J Meropol; K Robin Yabroff; C Weaver; Kevin Schulman
Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model.
Medical decision making : an international journal of the Society for Medical Decision Making 1998;18(1):84-94.
1998: Patrick J Creaven; Lakshmi Pendyala; Neal J Meropol; N J Clendeninn; E Y Wu; Gregory M Loewen; A Proefrock; A Johnston; M Dixon
Initial clinical trial and pharmacokinetics of Thymitaq (AG337) by 10-day continuous infusion in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 1998;41(2):167-70.
1997: Neal J Meropol; Diane C Noel; Daryl Sonnichsen; M J Birkhofer
Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Oncology (Williston Park, N.Y.) 1997;11(9 Suppl 10):22-5.
1997: David J Vaughn; Neal J Meropol; Christopher Holroyde; David M Mintzer; Isaac Nuamah; B Armstead; H O Douglass; Daniel G Haller
A phase II study of 5-fluorouracil, leucovorin, adriamycin, and cisplatin (FLAP) for metastatic gastric and gastroesophageal junction adenocarcinoma. A Penn Cancer Clinical Trial Group and Roswell Park Cancer Institute Community Oncology Research Program Trial.
American journal of clinical oncology 1997;20(3):242-6.
1997: N Soni; Neal J Meropol; Lakshmi Pendyala; Diane C Noel; L P Schacter; K E Gunton; Patrick J Creaven
Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):766-72.
1997: Patrick J Creaven; Raymond Perez; Lakshmi Pendyala; Neal J Meropol; Gregory M Loewen; E Levine; EJ Berghorn; D Raghavan
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancy.
Investigational new drugs 1997;15(3):227-34.
1996: Patrick J Creaven; D Raghavan; R P Perez; Lakshmi Pendyala; E J Berghorn; Gregory M Loewen; Neal J Meropol
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumors.
Seminars in oncology 1996;23(6 Suppl 16):26-31.
1996: M A Rodríguez-Bigas; Donald Klippenstein; Neal J Meropol; Thomas K. Weber; Nicholas J Petrelli
A pilot study of cryochemotherapy for hepatic metastases from colorectal cancer.
Cryobiology 1996;33(6):600-6.
1996: Neal J Meropol; R Pazdur; mark vincent; James Willson; David P Kelsen; H O Douglass
Phase II study of ZD1694 in patients with advanced gastric cancer.
American journal of clinical oncology 1996;19(6):628-30.
1996: J H North; Thomas K. Weber; Miguel A Rodriguez-Bigas; Neal J Meropol; Nicholas J Petrelli
The management of infectious and noninfectious anorectal complications in patients with leukemia.
Journal of the American College of Surgeons 1996;183(4):322-8.
1996: N Soni; Neal J Meropol; M Porter; Michael A Caligiuri
Diabetes mellitus induced by low-dose interleukin-2.
Cancer immunology, immunotherapy : CII 1996;43(1):59-62.
1996: Neal J Meropol; Nicholas J Petrelli; B J Lipman; Miguel A Rodriguez-Bigas; Wesley L Hicks; H O Douglass; J L Smith; M Rasey; LE Blumenson; L Vaickus; F A Hayes; J M Agosti
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery.
American journal of surgery 1996;172(3):299-302.
1996: Neal J Meropol; M Porter; L E Blumenson; Matthew Lindemann; R P Perez; L Vaickus; Gregory M Loewen; P J Creaven; K A Wilkes; M A Giedlin; M A Caligiuri
Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(4):669-77.
1996: Neal J Meropol; Youcef M Rustum; Nicholas J Petrelli; Miguel A Rodriguez-Bigas; C Frank; D H Ho; M Kurowski; Patrick J Creaven
A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer.
Cancer chemotherapy and pharmacology 1996;37(6):581-6.
1995: Neal J Meropol; Patrick J Creaven; Nicholas J Petrelli
Metastatic colorectal cancer: advances in biochemical modulation and new drug development.
Seminars in oncology 1995;22(5):509-24.
1995: Patrick J Creaven; D Raghavan; Lakshmi Pendyala; Raymond Perez; Gregory M Loewen; Neal J Meropol; E Levine; Wesley L Hicks
Phase I study of paclitaxel and carboplatin: implications for trials in head and neck cancer.
Seminars in oncology 1995;22(5 Suppl 12):13-6.
1995: Neal J Meropol; Nicholas J Petrelli; Youcef M Rustum; Miguel A Rodriguez-Bigas; LE Blumenson; C Frank; E Berghorn; Patrick J Creaven
A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patient with colorectal carcinoma.
Investigational new drugs 1995;13(2):149-55.
1995: brian stein; Nicholas J Petrelli; H O Douglass; D L Driscoll; G Arcangeli; Neal J Meropol
Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial.
Cancer 1995;75(1):11-7.
1994: Patrick J Creaven; Youcef M Rustum; Nicholas J Petrelli; Neal J Meropol; D Raghavan; Miguel A Rodriguez-Bigas; E G Levine; C Frank; S Udvary-Nagy; A Proefrock
Phase I and pharmacokinetic evaluation of floxuridine/leucovorin given on the Roswell Park weekly regimen.
Cancer chemotherapy and pharmacology 1994;34(3):261-5.